Chris Morrison

1.2k total citations
46 papers, 876 citations indexed

About

Chris Morrison is a scholar working on Public Health, Environmental and Occupational Health, Physiology and Reproductive Medicine. According to data from OpenAlex, Chris Morrison has authored 46 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Public Health, Environmental and Occupational Health, 20 papers in Physiology and 14 papers in Reproductive Medicine. Recurrent topics in Chris Morrison's work include Biomedical Ethics and Regulation (18 papers), Biotechnology and Related Fields (17 papers) and Science, Research, and Medicine (14 papers). Chris Morrison is often cited by papers focused on Biomedical Ethics and Regulation (18 papers), Biotechnology and Related Fields (17 papers) and Science, Research, and Medicine (14 papers). Chris Morrison collaborates with scholars based in United States, United Kingdom and Switzerland. Chris Morrison's co-authors include Walter O. Seiler, Peter Schmid, David Cox, Graeme Bilbe, H.B. Stähelin, N J Lüscher, Gary McMaster, Alessandro Di Rocco, David Dorfman and Peter Werner and has published in prestigious journals such as Nature Biotechnology, Nature Reviews Drug Discovery and The Journal of Pathology.

In The Last Decade

Chris Morrison

43 papers receiving 833 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris Morrison United States 14 506 154 118 118 85 46 876
Christian Kleist Germany 22 511 1.0× 213 1.4× 456 3.9× 342 2.9× 64 0.8× 56 1.3k
Ahlam Ali United Kingdom 18 494 1.0× 36 0.2× 103 0.9× 275 2.3× 142 1.7× 31 1.3k
Aditi Gupta United States 16 469 0.9× 71 0.5× 110 0.9× 215 1.8× 267 3.1× 39 945
Mary S. Rosendahl United States 18 604 1.2× 118 0.8× 227 1.9× 209 1.8× 47 0.6× 27 1.2k
Timo Burster Germany 23 510 1.0× 74 0.5× 201 1.7× 677 5.7× 38 0.4× 73 1.4k
David C. Briggs United Kingdom 20 576 1.1× 31 0.2× 82 0.7× 269 2.3× 89 1.0× 41 1.1k
Pascal Bigey France 30 1.3k 2.5× 120 0.8× 120 1.0× 259 2.2× 186 2.2× 71 2.0k
Dodie Pouniotis Australia 21 707 1.4× 136 0.9× 198 1.7× 764 6.5× 94 1.1× 41 1.4k
Shie-Liang Hsieh Taiwan 20 742 1.5× 87 0.6× 177 1.5× 676 5.7× 65 0.8× 44 1.5k
Mark Sutton‐Smith United Kingdom 21 1.3k 2.6× 201 1.3× 138 1.2× 586 5.0× 104 1.2× 29 2.0k

Countries citing papers authored by Chris Morrison

Since Specialization
Citations

This map shows the geographic impact of Chris Morrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Morrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Morrison more than expected).

Fields of papers citing papers by Chris Morrison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Morrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Morrison. The network helps show where Chris Morrison may publish in the future.

Co-authorship network of co-authors of Chris Morrison

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Morrison. A scholar is included among the top collaborators of Chris Morrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Morrison. Chris Morrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morrison, Chris. (2020). Fresh from the biotech pipeline—2019. Nature Biotechnology. 38(2). 126–131. 15 indexed citations
2.
Morrison, Chris. (2020). Industry shows increased appetite for macrophage biology. Nature Reviews Drug Discovery. 19(5). 295–297. 5 indexed citations
3.
Morrison, Chris. (2019). Fresh from the biotech pipeline—2018. Nature Biotechnology. 37(2). 118–123. 14 indexed citations
4.
Morrison, Chris. (2019). AACN President’s Annual Statement of the Academy Report. The Clinical Neuropsychologist. 34(1). 1–12. 4 indexed citations
5.
Morrison, Chris, et al.. (2019). Public biotech 2018—the numbers. Nature Biotechnology. 37(7). 714–721. 2 indexed citations
6.
Morrison, Chris. (2018). Boom: 2018's biotech IPOs. Nature Reviews Drug Discovery. 18(1). 3–6. 3 indexed citations
7.
Morrison, Chris. (2018). Alnylam prepares to land first RNAi drug approval. Nature Reviews Drug Discovery. 17(3). 156–157. 44 indexed citations
8.
Morrison, Chris. (2018). President’s Annual State of the Academy Report. The Clinical Neuropsychologist. 33(1). 1–12. 1 indexed citations
9.
Morrison, Chris. (2017). Landmark gene therapy poised for US approval. Nature Reviews Drug Discovery. 16(11). 739–741. 12 indexed citations
10.
Morrison, Chris, et al.. (2016). Public biotech in 2015 – the numbers. Nature Biotechnology. 34(7). 709–715. 11 indexed citations
11.
Morrison, Chris. (2016). Trump election sends aftershocks through biotech sector. Nature Biotechnology. 34(12). 1211–1212. 1 indexed citations
12.
Morrison, Chris. (2015). CAR-T field booms as next-generation platforms attract big players. Nature Biotechnology. 33(6). 571–572. 9 indexed citations
13.
Morrison, Chris. (2014). Developers seek to finetune toxicity of T-cell therapies. Nature Biotechnology. 32(12). 1171–1172. 3 indexed citations
14.
Morrison, Chris. (2014). First PI3k inhibitor launches into crowded hematology markets. Nature Biotechnology. 32(10). 963–964. 4 indexed citations
15.
Rocco, Alessandro Di, Teodoro Bottiglieri, David Dorfman, et al.. (2000). Decreased Homovanilic Acid in Cerebrospinal Fluid Correlates with Impaired Neuropsychologic Function in HIV-1-Infected Patients. Clinical Neuropharmacology. 23(4). 190–194. 41 indexed citations
16.
Schmid, Peter, David Cox, Graeme Bilbe, et al.. (1993). TGF‐βS and TGF‐β type II receptor in human epidermis: Differential expression in acute and chronic skin wounds. The Journal of Pathology. 171(3). 191–197. 107 indexed citations
17.
Morrison, Chris. (1988). Regulatory Idiotopes: Modern Concepts in Immunology Vol. 2. Vaccine. 6(4). 381–381. 1 indexed citations
18.
Morrison, Chris, et al.. (1984). Adjuvant-free immunological manipulation of livestock. Research in Veterinary Science. 37(1). 108–113. 4 indexed citations
19.
Morrison, Chris, et al.. (1981). Is idiotypic regulation the real thing?. Immunology Today. 2(7). 121–122. 1 indexed citations
20.
Morrison, Chris, et al.. (1976). Analysis of double-draped fenestration configurations. ASHRAE winter conference papers. 82. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026